MYGN (Myriad Genetics) Other Current Liabilities : $50.5 Mil (As of Mar. 2025)

View and export this data going back to 1995. Start your Free Trial

What is Myriad Genetics Other Current Liabilities?

Myriad Genetics's other current liabilities for the quarter that ended in Mar. 2025 was $50.5 Mil.

Myriad Genetics's quarterly other current liabilities increased from Sep. 2024 ($51.4 Mil) to Dec. 2024 ($64.9 Mil) but then declined from Dec. 2024 ($64.9 Mil) to Mar. 2025 ($50.5 Mil).

Myriad Genetics's annual other current liabilities increased from Dec. 2022 ($41.2 Mil) to Dec. 2023 ($49.7 Mil) and increased from Dec. 2023 ($49.7 Mil) to Dec. 2024 ($64.9 Mil).

Myriad Genetics Other Current Liabilities Historical Data

The historical data trend for Myriad Genetics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Myriad Genetics Other Current Liabilities Chart

Myriad Genetics Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Dec21

Dec22

Dec23

Dec24

Other Current Liabilities

Get a 7-Day Free Trial

47.40

52.80

41.20

49.70

64.90

Myriad Genetics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Current Liabilities	Get a 7-Day Free Trial															37.80	49.20	51.40	64.90	50.50

Myriad Genetics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

Myriad Genetics Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Myriad Genetics's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Myriad Genetics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Myriad Genetics Inc (NAS:MYGN) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

0K3W:UK MYD:Germany

Address

322 North 2200 West, Salt Lake City, UT, USA, 84116

Website

https://www.myriad.com

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

Executives

Paul J Diaz	director, officer: President and CEO	680 SOUTH FOURTH STREET, LOUISVILLE KY 40202
Dale Muzzey	officer: Chief Scientific Officer	322 NORTH 2200 WEST, SALT LAKE CITY UT 84116
Heinrich Dreismann	director	320 WAKARA WAY, SALT LAKE CITY UT 84108
Reitan Colleen F	director	300 THIRD STREET, CAMBRIDGE MA 02142
Margaret Ancona	officer: SVP, Chief of Staff	322 NORTH 2200 WEST, SALT LAKE CITY UT 84116
Rashmi Kumar	director	320 WAKARA WAY, SALT LAKE CITY UT 84108
Daniel K Spiegelman	director	MYRIAD GENETICS, 320 WAKARA WAY, SALT LAKE CITY UT 84003
Lee Nisley Newcomer	director	264 BUSHAWAY ROAD, WAYZATA MN 55391-1901
Richard Bryan Riggsbee	officer: Chief Financial Officer	322 NORTH 2200 WEST, SALT LAKE CITY UT 84116
Nicole Lambert	officer: Chief Operating Officer	322 NORTH 2200 WEST, SALT LAKE CITY UT 84116
Pamela Wong	officer: Chief Legal Officer	322 NORTH 2200 WEST, SALT LAKE CITY UT 84116
Shereen Solaiman	officer: Chief People Officer	320 WAKARA WAY, SALT LAKE CITY UT 84108
Paul Bisaro	director
Kevin Richard Haas	officer: Chief Technology Officer	322 NORTH 2200 WEST, SALT LAKE CITY UT 84116
Natalie Munk	officer: Chief Accounting Officer	322 NORTH 2200 WEST, SALT LAKE CITY UT 84116